Aimmune Therapeutics: 2Q Earnings Snapshot
Aug. 08, 2018
BRISBANE, Calif. (AP) _ Aimmune Therapeutics Inc. (AIMT) on Wednesday reported a loss of $52.6 million in its second quarter.
On a per-share basis, the Brisbane, California-based company said it had a loss of 91 cents.
The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 79 cents per share.
Aimmune Therapeutics shares have fallen 22 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $29.63, an increase of 44 percent in the last 12 months.